A man in his 20s with a history of classical Hodgkin's lymphoma was admitted with fever. His original lymphoma diagnosis was made 3 years prior, when he had presented with lymphadenopathy and a mediastinal mass. He had relapsed disease despite chemotherapy and radiation.
One month prior to presentation, surveillance CT scan showed near-resolution of the mediastinal mass and lymph nodes, but detected numerous new 2-to 8-mm lower-lobe pulmonary nodules. The patient was treated empirically with multiple antimicrobials and clinically improved; therefore, bronchoscopy was deferred because of anticipated low yield. The patient was ultimately discharged on voriconazole for suspected pulmonary aspergillosis, along with routine prophylaxis with trimethoprim/sulfamethoxazole and acyclovir. Over the 2 weeks leading up to presentation, he developed fevers and night sweats, without cough, chest pain, dyspnea, or hemoptysis. On admission, his temperature was 37. 6 C, and vitals were otherwise normal, including saturation of peripheral oxygen of 96% on ambient air. He appeared thin, with alopecia. He was breathing comfortably, with clear lungs on auscultation. He lacked palpable lymphadenopathy. Abdominal and testicular examinations were normal. His WBC count was normal.
Chest radiograph (Fig 1) showed basilar nodules that had not been apparent previously. Chest CT scan (Fig 2) revealed multiple nodules up to 10 mm, increased in size and number from the previous study. These had smooth borders and were concentrated in the bases and periphery in a vascular distribution, as suggested by the presence of feeding vessels.
Sputum and blood cultures for bacteria and fungi were negative, as were noninvasive fungal markers (urine histoplasma antigen, serum galactomannan, and cryptococcal antigen). Especially given the small and peripheral nature of the nodules, he underwent CT-guided transthoracic core needle biopsy.
Specimens showed a pleomorphic cellular infiltrate comprised of lymphocytes, eosinophils, histiocytes, and large cells with variably prominent nucleoli, moderate amounts of eosinophilic cytoplasm, and occasional atypical cells with bizarre-shaped nuclei embedded in a fibrous stroma (Fig 3) . Scattered large atypical monoand multinuclear cells with prominent nucleoli and abundant cytoplasm were present; these had strong staining for CD30, but lacked CD20 staining. CD15 was focally expressed in the cytoplasm of neoplastic cells. Flow cytometry (Fig 4) revealed an abnormal population comprised of cells with an immunophenotype shown in What is the diagnosis? Pulmonary nodules are commonly found during and after stem cell transplant (SCT), with the differential diagnosis divided into infectious and noninfectious etiologies. In the initial post-SCT period, prior to engraftment, infectious etiologies predominate and include septic emboli from bacteria or Candida species. The patient had engrafted, and although he had an indwelling central line, his blood cultures were negative.
In the early postengraftment period, infection is still most likely, and opportunistic pathogens become more common causes of nodular pneumonia. These can include atypical bacterial organisms, angioinvasive molds, and endemic mycoses. 2 Patients, particularly those receiving myeloablative conditioning regimens and those with chronic graft vs host disease, remain at risk for infectious etiologies in the late postengraftment period. Other opportunistic pathogens becoming important causes of nodular pneumonias in this period include Nocardia species, Mycobacterium tuberculosis, and nontuberculous mycobacteria.
The patient presented in the early postengraftement period, at which time angioinvasive molds such as aspergillus often account for infectious pulmonary nodules, 2 usually in the setting of prolonged neutropenia. However, the patient's neutropenia had resolved, and he had developed radiographic progression despite treatment with voriconazole at therapeutic levels. Mucormycosis, another angioinvasive mold, would not respond to voriconazole, but would again be unusual without neutropenia. Among endemic fungi, it is important to consider exposure history; the patient resided in the Pacific Northwest where Cryptococcus gattii is endemic, but lacked other relevant exposures. The serum cryptococcal antigen was negative, and although its test characteristics do not completely rule out pulmonary Cryptococcus in HIV-negative patients, 3 it did make infection less likely, as did the other noninvasive fungal studies for their respective infections.
Other fungal organisms, such as Scedosporium and Fusarium, were considered, but the indolent progression of his nodules did not fit with untreated disseminated fungal infection. Nocardia infection was considered less likely for the same reason, in addition to his regimen with prophylactic trimethoprim/sulfamethoxazole.
In the postengraftment period, noninfectious etiologies of lung nodules also become possible. Posttransplant lymphoproliferative disorder after allogeneic SCT occurs early, usually in the first year, and in association with Epstein-Barr virus (EBV) infection; the patient's Hodgkin's lymphoma had been EBV-negative, and whole blood polymerase chain reaction from this presentation was also undetectable, making EBV-associated posttransplant lymphoproliferative disorder unlikely. Pulmonary cytolytic thrombi can occur after SCT: associated with pain and fever, it is diagnosed by biopsy showing basophilic thromboemboli and hemorrhage. 4 Chemotherapeutic agents are associated with several patterns of pulmonary toxicity, but the patient's previous regimen was not associated with nodular pulmonary disease.
Finally, both solid tumors and lymphoproliferative disorders cause pulmonary nodules. The patient's age put him at risk for a germ cell tumor, but his testicular examination was normal.
Radiologic Discussion
The appearance and distribution of pulmonary nodules can help narrow the differential diagnosis. Among infectious causes, typical bacterial pathogens can cause solitary nodular consolidations; septic emboli cause peripheral nodules (often with cavitation). Although invasive pulmonary aspergillosis commonly causes nodular pneumonia, those nodules are often surrounded by ground glass (halo sign) because of angioinvasion and parenchymal hemorrhage; in this case, the nodules had smooth borders without ground glass components, making aspergillus less likely. The radiographic appearance of the nodules, taken together with clinical signs, including the indolent course, absence of cough and dyspnea, progression despite antimicrobial regimen, and absence of neutropenia all supported a noninfectious etiology. Among malignant causes of pulmonary nodules, different radiographic patterns are possible. Primary lung cancer does not usually present as multiple, small pulmonary nodules; however, intrapulmonary metastases can. Renal cell carcinoma and medullary thyroid cancer can cause multiple, small nodules; however, the latter often have a micronodular, miliary pattern.
Among lymphoproliferative disorders involving the pulmonary parenchyma, mucosal-associated lymphoid e32 Chest Imaging and Pathology for Clinicians tissue lymphoma presents as a solitary consolidation, whereas diffuse large B-cell lymphoma can cause multiple nodules. Lymphomatoid granulomatosis can cause large or small nodules.
Hodgkin's lymphoma commonly involves the thorax, but not the lung parenchyma: studies from the early era of CT scans showed that roughly 74% of patients with Hodgkin's lymphoma had mediastinal adenopathy on CT scan, whereas only 8% to 18% had lung involvement. 5, 6 Non-Hodgkin's lymphomas more commonly demonstrate parenchymal involvement. 6 
Pathologic Discussion
Determining the highest yield diagnostic approach for a pulmonary nodule can be challenging, but considering the pretest probability of the diagnoses in question can help choose the best technique. For instance, bronchoscopy with bronchoalveolar lavage has reasonably good yield for pulmonary infections in recipients of SCT, particularly when performed early. 7, 8 However, given the clinical and radiographic presentation, infection was considered less likely in this case; therefore bronchoalveolar lavage alone is unlikely to provide a diagnosis. In terms of biopsy techniques, the yield of bronchoscopy with transbronchial biopsy for malignancy varies depending on the location and size of the nodule, with small (< 2 cm) peripheral nodules yielding diagnoses as little as 14% of the time, but larger, more central nodules having higher yields (up to 91% for > 4-cm nodules). 9 Transthoracic core needle biopsy has a higher diagnostic yield for malignancy (70%-80% in nodules # 15 mm and 90% in nodules > 15 mm), but carries an approximately 15% risk of pneumothorax (although only approximately one-half of these will require tube thoracostomy). 10 Characteristics that increase pneumothorax risk include presence of emphysema, small lesion size (< 20 mm), need to cross a fissure to access the lesion, and length of lung traversed by the needle. 11 Indeed, the patient did experience a pneumothorax after biopsy but did not require intervention.
The biopsy demonstrates an immunophenotype consistent with classical Hodgkin's lymphoma (Table 1) . However, the imaging findings are unusual. One potential explanation for peripheral, basilar nodules with feeding vessels in Hodgkin's lymphoma is hematogenous dissemination of residual tumor cells (RTCs) during autologous transplantation. RTCs have been found in autologous stem cell collections from patients with a range of solid and hematologic malignancies. Cell reinfusion at the time of autologous SCT has been proposed as a mechanism of relapse. This phenomenon has been reported in leukemias, breast cancer, neuroblastoma, multiple myeloma, and non-Hodgkin's lymphoma. 12 Patients with RTCs have been found to have higher relapse rates; however, consensus is lacking on whether relapse is caused by RTCs themselves or by those patients simply having a higher burden or more aggressive disease (of which RTCs are a marker). Many patients who relapse after autologous SCT do so at their original disease sites, not in new sites that would be consistent with hematogenous spread 13 ; however, the patient presented here lacked pulmonary parenchymal disease prior to initial SCT. In fact, his original disease site (the mediastinum) had responded quite well to prior treatments. Accelerated growth of the nodules in this case was likely because of his immunosuppression.
Conclusions
This case of hematogenous spread of Hodgkin's lymphoma to the lung has important implications for practicing pulmonologists. First, the differential diagnosis of pulmonary nodules after SCT is broad and includes both infectious and noninfectious etiologies. Biopsy may be required for diagnosis, and the approach should take into account both patient and procedural factors. Second, Hodgkin's lymphoma should be considered in the differential of nodular pulmonary disease. Finally, tumor cell contamination should be considered as a cause of relapsed disease after SCT.
